Industry: Pharmaceuticals, Biotechnology
Cytomedix, Inc. is a biotechnology company specializing in processes and products derived from autologous platelet releasates for uses in the treatment of wounds and other applications. The current offering is AutoloGel, a technology that utilizes an autologous platelet gel composed of multiple growth factors and fibrin matrix. The Company has announced favorable results from its blinded, prospective, multi-center clinical trial on the use of its technology in healing diabetic foot ulcers and is appealing the FDA’s ruling related to its 510(k) application for marketing clearance for a new product seeking specific labeled indications for the healing of chronic wounds. ( www.cytomedix.com )
Cytomedix , Inc.
416 Hungerford Drive Suite 330
Rockville, Maryland 20850
USA
Tel: (240) 499-2680
Fax: (240) 499-2690